nitroaspirin has been researched along with Disease Models, Animal in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (9.09) | 18.2507 |
2000's | 7 (63.64) | 29.6817 |
2010's | 3 (27.27) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Güç, MO; Iskit, AB; Sökmensüer, C; Ulu, N | 1 |
Bria, P; Di Gioia, A; Pomponi, M; Pomponi, MF | 1 |
Abdellatif, KR; Chattopadhyay, M; Kashfi, K; Keefer, LK; Nia, KV; Pruski, A; Velazquez, CA | 1 |
Bolla, M; Daemen, MJ; Gijbels, MJ; Heeneman, S; Hoving, S; Pol, JF; Russell, NS; Simons, MY; Stewart, FA; te Poele, JA | 1 |
Gresele, P; Mezzasoma, AM; Momi, S | 1 |
Del Soldato, P; Emanueli, C; Madeddu, P; Monopoli, A; Ongini, E; Salis, MB; Van Linthout, S | 1 |
Alberti, PF; Del Soldato, P; Gresele, P; Minuz, P; Momi, S; Pitchford, SC | 1 |
Granger, DN; Specian, RD; Tailor, A; Wallace, JL; Wood, KC | 1 |
Bak, AW; Calignano, A; Cirino, G; Del Soldato, P; Li, P; McKnight, W; Wallace, JL | 1 |
Del Soldato, P; Emerson, M; Gresele, P; Leone, M; Mezzasoma, AM; Momi, S; Page, CP; Paul, W | 1 |
Abete, P; Aldini, G; Bonaduce, D; Condorelli, G; Condorelli, M; D'Armiento, FP; de Nigris, F; de Rosa, G; Ignarro, LJ; Lerman, LO; Maffei, R; Mignogna, C; Napoli, C; Rengo, F; Sica, V; Wallace, JL | 1 |
11 other study(ies) available for nitroaspirin and Disease Models, Animal
Article | Year |
---|---|
The effects of aspirin, flurbiprofen, and NO-donating acetylsalicylic acid (NCX 4016) on mice models of endotoxic and septic shock.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Disease Models, Animal; Flurbiprofen; Liver; Male; Mice; Shock, Septic; Spleen; Treatment Outcome | 2015 |
Fatty aspirin: a new perspective in the prevention of dementia of Alzheimer's type?
Topics: Alzheimer Disease; Animals; Antioxidants; Aspirin; Cognition Disorders; Dementia; Disease Models, Animal; Docosahexaenoic Acids; Hippocampus; Memory; Mice; Microglia; Neurofibrillary Tangles; Neuronal Plasticity; Synapses | 2008 |
Comparison between 3-Nitrooxyphenyl acetylsalicylate (NO-ASA) and O2-(acetylsalicyloxymethyl)-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate (NONO-ASA) as safe anti-inflammatory, analgesic, antipyretic, antioxidant prodrugs.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Antipyretics; Aspirin; Dinoprostone; Disease Models, Animal; Edema; Fever; Gastric Mucosa; Hydrazines; Hyperalgesia; Lipid Peroxidation; Male; Malondialdehyde; Molecular Structure; Prodrugs; Rats; Rats, Wistar; Stomach Ulcer; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2010 |
NO-donating aspirin and aspirin partially inhibit age-related atherosclerosis but not radiation-induced atherosclerosis in ApoE null mice.
Topics: Age Factors; Animals; Apolipoproteins E; Aspirin; Atherosclerosis; Carotid Arteries; Disease Models, Animal; Down-Regulation; Female; Gene Expression; Humans; Intercellular Adhesion Molecule-1; Male; Mice; Mice, Inbred C57BL; Platelet Aggregation; Vascular Cell Adhesion Molecule-1; X-Rays | 2010 |
NCX4016: a novel antithrombotic agent.
Topics: Animals; Aspirin; Blood Platelets; Disease Models, Animal; Fibrinolytic Agents; Humans; In Vitro Techniques; Mice; Monocytes; Nitric Oxide; Platelet Aggregation Inhibitors; Pulmonary Embolism; Rabbits; Rats | 2003 |
Nitric oxide-releasing aspirin derivative, NCX 4016, promotes reparative angiogenesis and prevents apoptosis and oxidative stress in a mouse model of peripheral ischemia.
Topics: Animals; Apoptosis; Aspirin; Disease Models, Animal; Down-Regulation; Gene Expression Regulation; Male; Mice; Mice, Inbred Strains; Muscle, Skeletal; Neovascularization, Physiologic; Nitric Oxide; Nitrites; Oxidative Stress; Reperfusion Injury; Vascular Endothelial Growth Factor A | 2004 |
Nitroaspirin plus clopidogrel versus aspirin plus clopidogrel against platelet thromboembolism and intimal thickening in mice.
Topics: Animals; Aspirin; Blood Coagulation Tests; Clopidogrel; Disease Models, Animal; Drug Therapy, Combination; Hemorrhage; Male; Mice; Mice, Inbred Strains; Platelet Aggregation; Platelet Aggregation Inhibitors; Pulmonary Embolism; Survival Rate; Thromboembolism; Ticlopidine; Tunica Intima | 2005 |
Roles of platelet and endothelial cell COX-1 in hypercholesterolemia-induced microvascular dysfunction.
Topics: Animals; Aspirin; Blood Platelets; Bone Marrow Transplantation; Cardiovascular Diseases; Cell Adhesion; Chimera; Cholesterol, Dietary; Cyclooxygenase 1; Cyclooxygenase Inhibitors; Disease Models, Animal; Endothelial Cells; Endothelium, Vascular; Hypercholesterolemia; Leukocytes; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Microscopy, Fluorescence; Microscopy, Video; Nitric Oxide Donors; Platelet Adhesiveness; Pyrazoles; Venules | 2007 |
Cyclooxygenase-independent chemoprevention with an aspirin derivative in a rat model of colonic adenocarcinoma.
Topics: Adenocarcinoma; Animals; Aspirin; Azoxymethane; Colonic Neoplasms; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Disease Models, Animal; Isoenzymes; Male; Membrane Proteins; Mice; Pain Measurement; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; Trinitrobenzenesulfonic Acid | 1998 |
Prevention of pulmonary thromboembolism by NCX 4016, a nitric oxide-releasing aspirin.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Aspirin; Disease Models, Animal; Dose-Response Relationship, Drug; Injections, Intravenous; Lung; Male; Mice; Nitroarginine; Platelet Aggregation Inhibitors; Platelet Count; Pulmonary Artery; Pulmonary Embolism; Rabbits; Thrombin; Thrombosis | 2000 |
Efficacy and age-related effects of nitric oxide-releasing aspirin on experimental restenosis.
Topics: Aging; Angioplasty, Balloon, Coronary; Animals; Aspirin; Coronary Restenosis; Coronary Vessels; Disease Models, Animal; Fibrinolytic Agents; Hemoglobins; Nitrates; Nitric Oxide; Nitric Oxide Donors; Nitrites; Rats; Rats, Sprague-Dawley; Time Factors; Tunica Intima | 2002 |